GS Gl.F.Health C.Eq.R GBP
WKN A2QBR8 | ISIN LU2220396225 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU2384387564 | CPR Invest - MedTech - A HUF - Acc | +27,75 % | +14,33 % | 1,76 |
|
| 2 | LU2036817398 | CPR Invest - MedTech - I EUR - Acc | +20,24 % | +12,33 % | 1,43 |
|
| 3 | LU2036817711 | CPR Invest - MedTech - R EUR - Acc | +19,79 % | +12,32 % | 1,39 |
|
| 4 | LU2125047428 | CPR Invest - MedTech - M2 EUR - Acc | +19,62 % | +12,32 % | 1,38 |
|
| 5 | LU2067132592 | CPR Invest - MedTech - I uk GBP - Acc | +18,84 % | +11,68 % | 1,39 |
|
| 189 | LU2220396225 | GS Gl.F.Health C.Eq.R GBP | +4,59 % | +11,61 % | 0,17 |
|
| 443 | LU2053353582 | JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) | -12,92 % | +21,09 % | -0,74 |
|
| 444 | LU2098775385 | JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged) | -12,98 % | +21,08 % | -0,74 |
|
| 445 | IE00BYW5L636 | Wellington Global Health Care Equity Fund SGD D AccH | -4,92 % | +12,45 % | -0,61 |
|
| 446 | LU2053353400 | JPMorgan Funds - Thematics - Genetic Therapies A (acc) - CHF (hedged) | -13,39 % | +21,08 % | -0,76 |
|
| 447 | LI0507461338 | GF Global Cannabis Opportunity Fund EUR | -23,07 % | +27,97 % | -0,92 |
|